Navigation Links
Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
Date:12/3/2008

WORCESTER, Mass. Dec. 3, 2008 Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system. Having either too much or too little interleukin-12 may play a role in the development of many diseases, including some cancers and auto-immune disorders like Crohn's, psoriasis, and rheumatoid arthritis. In turn, modulating interleukin-12 levels could yield new therapies for those conditions.

In an effort to create a new and cost-effective method for producing interleukin-12 and make more of the scarce protein available for research and therapeutic development, a team of scientists at Worcester Polytechnic Institute's Life Sciences and Bioengineering Center (WPI) and the Arkansas Bioscience Institute at Arkansas State University (ABI) reports that hairy roots from genetically modified tobacco plants can be grown in a contained novel mist bioreactor system, yielding significant quantities of murine interleukin-12. A paper detailing the results of the study has been published early, online, by the journal Biotechnology and Bioengineering and will appear in the journal's printed edition early in 2009.

"We are very encouraged by the results of this study," says Pamela J. Weathers, PhD, professor of biology and biotechnology at WPI, co-author of the paper. "Interluekin-12 is a valuable protein and there just isn't enough available for biomedical research, let alone for therapeutic development. Our study shows that we can use plants to produce interleukin-12, and other therapeutic proteins, in a cost-effective controlled process."

The tobacco project is one of several emerging collaborative efforts between WPI and ABI. In the current study, tobacco plants were modified in the lab of Carole Cramer, PhD, ABI's executive director and co-author of the paper. Cramer's team successfully inserted into tobacco plants a mouse gene that directs the production of interleukin 12. Hairy root cultures fr
'/>"/>

Contact: Michael Cohen
mcohen@wpi.edu
508-868-4778
Worcester Polytechnic Institute
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Novel Techniques Offers New Freedom to Patients with Parkinson's Disease, Epilepsy, Dystonia, and Tremor
2. USC researchers identify novel approach for suppressing prostate cancer development
3. Studies show novel device may enhance chemotherapy treatment in brain tumors
4. Labopharm to host webcast presentation on novel trazodone formulation for treatment of major depressive disorder
5. Labopharms NDA for Novel Trazodone Formulation accepted for review by FDA
6. E6 Ventures Invests in Novel Coatings Developer, Diamond Hard Surfaces Ltd
7. Novel imaging technique reveals brain abnormalities that may play key role in ADHD
8. Future Looks Bright For Non-Invasive Diagnosis Of Skin Cancer; Study Shows Novel Light Device Detects Cancerous Lesions From Normal Tissue
9. Novel IBS treatment developed at UB garners $8.5 million for seven-year clinical trial
10. Novel 4-drug combination proves safe for lung cancer treatment
11. Porter Novelli Named Agency of Record for Pharmavite(R) LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Children had half as many emergency department visits if ... five or more days a week, according to new ... Hospital and Johns Hopkins University. , The new study ... of Pediatrics and will be presented at the ... important step in understanding where primary care practices and ...
(Date:6/19/2013)... are increasingly common on college campuses, but are ... up"? A new study by researchers with The ... published online by the Archives of Sexual ... behaviors associated with sexual hookups, particularly among first-year ... negative emotional and physical health outcomes as a ...
(Date:6/19/2013)... block the body,s system for repairing damage to the ... unlikely as it may seem, those compounds are sparking ... driven by a mutation in BRCA, a gene that ... the mutation. The compounds, termed PARP inhibitors, are the ... of Chemical & Engineering News . C&EN is ...
(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...
(Date:6/19/2013)... Alternatives, a revolutionary new treatment facility located ... drugs while allowing them to continue drinking alcohol. Drs. ... believe that abstinence-only approaches force people to wait until ... this approach hurts instead of helping. It is ... need treatment for addiction but only 3 million seek ...
Breaking Medicine News(10 mins):Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3
... way to treat castrate resistant cells in prostate cancer ... For more than 60 years the main way ... the hormones that fuel growth of the cancer cells. ... the tumour growth resumes, the disease in incurable. The ...
... , ... ... ... ...
... ... ... ... ...
... ... ... of complex government regulation some of the stand-out questions include:, , ,   ... How are these standards impacted by the convergence of media and conflation of traditional media ...
... ... ... ... ...
... ... ... ... ...
Cached Medicine News:Health News:Effective prostate cancer treatment discovery 2Health News:Verizon Health Care IT Experts to Present at Atlanta Conference on March 2, 3 2Health News:Verizon Health Care IT Experts to Present at Atlanta Conference on March 2, 3 3Health News:Verizon Health Care IT Experts to Present at Atlanta Conference on March 2, 3 4Health News:AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on 'Inside Government' Radio Show 2Health News:AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on 'Inside Government' Radio Show 3Health News:AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on 'Inside Government' Radio Show 4Health News:AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on 'Inside Government' Radio Show 5Health News:AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on 'Inside Government' Radio Show 6Health News:AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on 'Inside Government' Radio Show 7Health News:Alan Chapell, President of Chapell & Associates to Deliver Keynote at the Next AdMonsters US Leadership Forum 2Health News:Alan Chapell, President of Chapell & Associates to Deliver Keynote at the Next AdMonsters US Leadership Forum 3Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 2Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 3Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 4Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 5Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 6Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 7Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 8Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 2Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 3Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 4Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 5Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 6
(Date:6/19/2013)... /PRNewswire-iReach/ -- Today leading web researchers Change Sciences Group ... web sites for usability, engagement, and conversion. The rankings ... which compares how people experience sites with competitors and ... The top three performers are easier to use, more ... performers have usability problems, lack aspects of design that ...
(Date:6/19/2013)... , June 19, 2013 Today MedeAnalytics, ... introduced the next-generation of its Employer Group ... health plans to provide their employer groups an ... factors, medical and prescription drug claims, network utilization, ... http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer Group ...
(Date:6/18/2013)... Quebec , June 18, 2013 Valeant ... TSX: VRX) (the "Company") announced today that VPII Escrow ... the Company, has launched its offer of approximately $3.2 ... "Notes").  The Notes will be due in 2021 and ... The Company intends to use the net proceeds ...
Breaking Medicine Technology:Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3
... 2011 When consumers are offered a cost-neutral choice ... store or through a mail-order pharmacy, they split their ... study from CVS Caremark (NYSE: CVS ) ... study, published in the January edition of the ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced ... BMN 701, a novel fusion protein of insulin-like growth factor ... treatment of Pompe disease. "We have a strong ... medical needs and expect to leverage our clinical and regulatory ...
Cached Medicine Technology:CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions 2CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions 3BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease 2BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease 3
... Blood Collection Tubes are used ... blood samples for use with ... chemistry cartridges requiring either 95 ... sample. These tubes are Mylar-wrapped ...
... FEMTO LDV, the first compact, mobile femtosecond ... a versatile, powerful platform for a wide ... basic system addresses the demand of refractive ... is consistent with an efficient LASIK work-flow. ...
Safilo Design, a state-of-the art ophthalmic collection that blends technology with minimalist sophistication. Each style comes with a sleek silver-colored hard case with magnetic closure....
Classic, stylish, and preppy, this collection features men's, women's and unisex styles....
Medicine Products: